What is Mae?
Mae operates as a specialized digital health platform dedicated to improving pregnancy outcomes through culturally competent care and resource navigation. The company functions at the intersection of health equity and technology, providing a robust framework that connects patients with the support systems necessary to navigate a complex healthcare environment. By working in concert with payers and state entities, Mae addresses the root causes of maternal health disparities, effectively serving as a bridge between clinical care and community-based support. Its market position is defined by its mission-driven approach to reducing systemic risk, making it a vital component in the push for equitable healthcare delivery in the United States.
How much funding has Mae raised?
Mae has raised a total of $1.3M across 1 funding round:
Angel/Seed
$1.3M
Angel/Seed (2021): $1.3M with participation from Avestria Ventures, SteelSky Ventures, MBX Capital, and Rhia Ventures
Key Investors in Mae
SteelSky Ventures
SteelSky Ventures is a visionary venture fund focused on investing in companies that enhance access, care, and outcomes in women's health, supporting innovations across consumer and digital health.
MBX Capital
MBX Capital is a boutique venture capital firm that partners with and creates healthcare and biotechnology companies that are disrupting conventions in service to public health.
Rhia Ventures
Rhia Ventures is dedicated to creating a just reproductive and maternal health market in the United States by engaging investors, activists, and entrepreneurs to advance health equity.
What's next for Mae?
With the successful closure of this funding round, Mae is poised to accelerate its strategic roadmap, focusing on the expansion of its digital ecosystem and the deepening of its institutional partnerships. The company is expected to leverage this capital to enhance its platform capabilities, potentially integrating more advanced data analytics to track and improve maternal health metrics at scale. Furthermore, the focus will likely remain on scaling its collaborative model with healthcare payers to ensure that its services are integrated into standard care pathways. As the firm matures, its ability to demonstrate measurable improvements in health outcomes will be the primary metric for future growth and potential subsequent financing rounds, solidifying its role as a leader in the women's health technology sector.
See full Mae company page
